Skip to main content
SpringerLink
Log in
Book cover

Encyclopedia of Metagenomics pp 1–6Cite as

Intestinal Microbiota, Alterations in Irritable Bowel Syndrome

  • Living reference work entry
  • First Online:

  • 156 Accesses

Synonyms

Irritable bowel syndrome (IBS); Plural (spp.); Species

Introduction

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders affecting between 10 % and 20 % of adults in the industrialized world. People suffering from IBS report more ailments than the general population and commonly incur a diminution in their quality of life. IBS is defined by abdominal pain, gas, bloating or discomfort, rectal hypersensitivity, and altered bowel habits. However, these characteristics are shared with a number of other gastrointestinal disorders. IBS is therefore commonly identified by its characteristics and through elimination of organic gastrointestinal disorders such as irritable bowel disease (IBD) and celiac disease. There are four main types of IBS as defined by their characteristics: IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), IBS with an alternating subtype (IBS-A), and IBS that is un-subtyped (IBS-U)

The etiology of IBS is as yet...

This is a preview of subscription content, log in via an institution.

References

  • Arumugam M, Raes J, Pelletier E, Paslier DL, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson M-P, Dechelotte P, Bommelaer G, Eschalier A, Ardid D. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology. 2005;128:1996–2008.

    Article  CAS  PubMed  Google Scholar 

  • Codling C, O’Mahony L, Shanahan F, Quigley EMM, Marchesi JR. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci. 2010;55:392–7.

    Article  PubMed  Google Scholar 

  • Duncan SH, Louis P, Thomson JM, Flint HJ. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol. 2009;11:2112–22.

    Article  PubMed  Google Scholar 

  • El-Salhy M. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep. 2012;5:1382–90.

    PubMed  Google Scholar 

  • Jeffery IB, O’Toole PW, Ohman L, Claesson MJ, Deane J, Quigley EMM, Simrén M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61:997–1006.

    Article  PubMed  Google Scholar 

  • Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Hunter JO, Cole JA. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn’s disease? FEMS Microbiol Lett. 2010;310:138–44.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol. 2009;15:5936–45.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Malinen E, Krogius-Kurikka L, Lyra A, Nikkilä J, Jääskeläinen A, Rinttilä T, Vilpponen-Salmela T, von Wright AJ, Palva A. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol. 2010;16:4532–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163–73.

    Article  PubMed  Google Scholar 

  • Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl Med. 2011;364:22–32.

    Article  CAS  Google Scholar 

  • Quigley EMM. Do patients with functional gastrointestinal disorders have an altered gut flora? Ther Adv Gastroenterol. 2009;2:23–30.

    Article  Google Scholar 

  • Rajilić–Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141:1792–801.

    Article  PubMed  Google Scholar 

  • Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology. 2010;156:3205–15. Reading, Engl.

    Article  CAS  PubMed  Google Scholar 

  • Saulnier DM, Riehle K, Mistretta T-A, Diaz M-A, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology. 2011;141:1782–91.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Schoepfer AM, Schaffer T, Seibold-Schmid B, Müller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil. 2008;20:1110–8.

    Article  CAS  PubMed  Google Scholar 

  • Serra J, Villoria A, Azpiroz F, Lobo B, Santos J, Accarino A, Malagelada J-R. Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22(401–406):e91–2.

    Google Scholar 

  • Valeur J, Berstad A. Colonic fermentation: a neglected topic in human physiology education. Adv Physiol Educ. 2010;34, 22.

    Google Scholar 

  • Whelan K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care. 2011;14:581–7.

    Article  PubMed  Google Scholar 

  • Yong E. Gut microbial “enterotypes” become less clear-cut. Nature News, March 21 2012 (http://www.nature.com/news/gut-microbial-enterotypes-become-less-clear-cut-1.10276) (2012).

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland

    Ian B. Jeffery & Marcus J. Claesson

  2. University College Cork, Corcaigh, Ireland

    Paul O’Toole

Authors
  1. Ian B. Jeffery
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcus J. Claesson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul O’Toole
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian B. Jeffery .

Editor information

Editors and Affiliations

  1. J. Craig Venter Institute (JCVI), Rockville, Maryland, USA

    Karen E. Nelson

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this entry

Cite this entry

Jeffery, I.B., Claesson, M.J., O’Toole, P. (2012). Intestinal Microbiota, Alterations in Irritable Bowel Syndrome. In: Nelson, K. (eds) Encyclopedia of Metagenomics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6418-1_96-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6418-1_96-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-6418-1

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation